30 results
8-K
EX-10.4
AVRW
Avenir Wellness Solutions, Inc.
28 Jul 22
CURE Pharmaceutical Announces the Sale of a Portion of its Platform Technology IP for $20 Million
9:51am
, reimbursement or similar rights against Seller with respect to this Guaranty until the payment or satisfaction of the Obligations indefeasibly in full … , the right of Guarantor to proceed against Seller for reimbursement, or both;
(e) any duty on the part of any Beneficiary to disclose to Guarantor any facts
8-K
EX-10.7
AVRW
Avenir Wellness Solutions, Inc.
28 Jul 22
CURE Pharmaceutical Announces the Sale of a Portion of its Platform Technology IP for $20 Million
9:51am
by Executive in the performance of Executive’s duties to the Company in accordance with the Company’s expense reimbursement Policy.
(c) Options
S-3
3wfmlkise3dhkx
30 Nov 20
Shelf registration
5:23pm
8-K
EX-10.7
lthblwlt
2 Nov 20
CURE Pharmaceutical Closes $10 Million Financing
4:05pm
8-K
EX-10.1
a8fv9vd0023cjib kps
2 Nov 20
CURE Pharmaceutical Closes $10 Million Financing
4:05pm
8-K
EX-10.2
hc0bt1tvpv7j 2ucs
5 Oct 20
Entry into a Material Definitive Agreement
8:16am
8-K
EX-2.1
dleo3kmkp5ehxtq8h9fz
5 Oct 20
Entry into a Material Definitive Agreement
8:16am
8-K/A
EX-2.1
81j4g zyt1zv4kh5qk1
31 Dec 19
Completion of Acquisition or Disposition of Assets
12:15pm
8-K
EX-3.3
zdghno4ayu
4 Oct 19
Material Modifications to Rights of Security Holders
2:07pm
PRER14A
bfg86akyk
26 Jun 19
Preliminary revised proxy
3:54pm
PRE 14A
xru8gn7ff9 g1
14 Jun 19
Preliminary proxy
5:27pm
8-K
EX-10.1
38m129h4zhpnp
20 May 19
CURE Pharmaceutical Expands Leadership Team with Key New Hires
4:39pm